Insulin Resistance in Pediatric Obesity: From Mechanisms to Treatment Strategies

Yu Luo1, Dan Luo2, Maojun Li1

  • 1Department of Pediatrics Sichuan Provincial People's Hospital School of Medicine University of Electronic Science and Technology of China, Chengdu, China.

Pediatric Diabetes
|April 30, 2025
PubMed

Insights

Childhood obesity is linked to insulin resistance, increasing type 2 diabetes risk. This review explores mechanisms and treatments for improving insulin sensitivity in pediatric obesity.

Area of Science:

  • Pediatric Endocrinology
  • Metabolic Disorders
  • Obesity Research

Background:

  • Insulin resistance is common in obese children and adolescents.
  • It significantly contributes to type 2 diabetes mellitus (T2DM) and metabolic diseases.
  • Insulin resistance involves decreased tissue sensitivity to insulin, impairing glucose metabolism.

Purpose of the Study:

  • To elucidate the mechanisms of insulin resistance in childhood obesity.
  • To review risk factors contributing to obesity-related insulin resistance.
  • To discuss treatment strategies focused on improving insulin sensitivity in pediatric obesity.

Main Methods:

  • Comprehensive analysis of relevant literature and studies.
  • Examination of underlying mechanisms of insulin resistance.
  • Review of risk factors such as lipid disorders, oxidative stress, mitochondrial dysfunction, inflammation, and genetics.

Main Results:

  • Identified key contributors to pediatric insulin resistance including lipid metabolism disorders, oxidative stress, mitochondrial dysfunction, inflammation, and genetic factors.
  • Highlighted the incomplete understanding of these mechanisms in childhood obesity.
  • Emphasized the link between obesity, insulin resistance, and T2DM development.

Conclusions:

  • Understanding the mechanisms of insulin resistance in pediatric obesity is crucial.
  • Targeting insulin sensitivity offers a pathway for managing pediatric obesity and preventing T2DM.
  • Further research and targeted interventions are needed for effective prevention and management.

Related Concept Videos

Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
134
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.3K
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
1.1K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
216
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
356
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
10.7K